Grifols Accounts Payable:
281.15M for March 31, 2013Grifols Historical Accounts Payable Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 281.15M |
| Dec. 31, 2012 | 302.64M |
| Sept. 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| Dec. 31, 2011 | 363.70M |
| Sept. 30, 2011 | |
| June 30, 2011 | |
| Dec. 31, 2010 | 212.49M |
| June 30, 2010 | 155.64M |
| Dec. 31, 2009 | 173.41M |
About Accounts Payable
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
For example, accounts payable increases when a company purchases inventory "on account." When the money is repaid, accounts payable decreases.
YCharts takes accounts payable numbers directly from balance sheet line items.
Learn More
GRFS Accounts Payable Benchmarks
| Companies | |
|---|---|
| Cadence Pharmaceuticals | 5.808M |
| Gilead Sciences | 1.327B |
| ARCA biopharma | 0.065M |
GRFS Accounts Payable Rankings
| Overall |
92nd percentile 622 of 8007 |
| Sector |
95th percentile 33 of 685 in Healthcare |
| Industry |
98th percentile 4 of 248 in Biotechnology |
GRFS Accounts Payable Range, Past 5 Years
| Minimum | 155.64M | Jun 2010 |
| Maximum | 363.70M | Dec 2011 |
| Average | 248.17M |
